Dyslipidemia in Chronic Kidney Disease

Authors

  • N Sultana Professor of Biochemistry, Additional Director General (Administration) Directorates General of Health Services (DGHS), Dhaka

DOI:

https://doi.org/10.3329/bjmb.v12i2.71602

Keywords:

Chronic kidney disease, Renal failure, Dyslipidemia, Hypertriglyceridemia, Hemodialysis, Peritoneal dialysis

Abstract

Globally chronic kidney (CKD) disease is one of the major health problems. Global prevalence of CKD is 8−16%. Prevalence of chronic kidney disease in Bangladesh is 26%. Patients with chronic kidney disease (CKD) exhibit significant alterations in lipoprotein metabolism. In this review different lipid parameters are shown from different studies and the pathogenesis of CKD induced dyslipidemia is discussed.

Bangladesh J Med Biochem 2019; 12(2): 31-38    

Downloads

Abstract
168
PDF
233

Downloads

Published

2024-02-19

How to Cite

Sultana, N. (2024). Dyslipidemia in Chronic Kidney Disease. Bangladesh Journal of Medical Biochemistry, 12(2), 31–38. https://doi.org/10.3329/bjmb.v12i2.71602

Issue

Vol. 12 No. 2 (2019)

Section

Review Articles